Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.
暂无分享,去创建一个
[1] T. Ishibashi,et al. Morphologic observations on experimental subretinal neovascularization in the monkey. , 1987, Investigative ophthalmology & visual science.
[2] J. Bennett,et al. Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse , 1998, Gene Therapy.
[3] E. Adamson,et al. Down-regulation of epidermal growth factor receptors in mouse embryos. , 1982, Developmental biology.
[4] K. Nakagawa,et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[5] T. Veikkola,et al. VEGFs, receptors and angiogenesis. , 1999, Seminars in cancer biology.
[6] E. Rodriguez-Boulan,et al. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires αvβ5 integrin for binding but not for internalization , 1997 .
[7] L. Aiello,et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. , 1998, Diabetes.
[8] S. Seregard,et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.
[9] C. Puliafito,et al. A new model of experimental choroidal neovascularization in the rat. , 1989, Archives of ophthalmology.
[10] K. Csaky,et al. Saturation of, and competition for entry into, the apical secretory pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Csaky,et al. Recombinant adenovirus-mediated gene transfer into the adult rat retina. , 1998, Current eye research.
[12] P. D. de Jong,et al. Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.
[13] Hanns Lochmüller,et al. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. , 1994, Human gene therapy.
[14] H. Blau,et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. , 1998, Molecular cell.
[15] R. Crystal,et al. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. , 1997, Human gene therapy.
[16] F. Ferris,et al. Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.
[17] H. Hurst,et al. Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. , 1996, Gene therapy.
[18] P. Campochiaro,et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.
[19] Hanns Lochmüller,et al. Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 Cells , 1994 .
[20] R. Crystal,et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. , 1998, Journal of vascular surgery.
[21] R. Worton,et al. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. , 1997, Human gene therapy.
[22] A. Passaniti,et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. , 1995, Circulation research.
[23] E. Adamson,et al. Functional EGF receptors are present on mouse embryo tissues , 1981, Nature.
[24] J. Whitsett,et al. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. , 1995, Human gene therapy.
[25] P. Campochiaro,et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.
[26] H. Kaplan,et al. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. , 1995, American journal of ophthalmology.
[27] I. Constable,et al. Generation and characterization of a recombinant adenovirus expressing vascular endothelial growth factor for studies of neovascularization in the eye. , 1999, Australian and New Zealand journal of ophthalmology.
[28] P. Campochiaro,et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.
[29] N. Bressler,et al. Clinicopathologic Correlation of Occult Choroidal Neovascularization in Age-Related Macular Degeneration , 1992, Archives of ophthalmology.
[30] T. Ishibashi,et al. Pathogenesis of laser-induced choroidal subretinal neovascularization. , 1990, Investigative ophthalmology & visual science.
[31] Thomas N. Sato,et al. Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.
[32] D. Hinton,et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.
[33] K. Nakagawa,et al. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[34] A Kijlstra,et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, American Journal of Pathology.
[35] Hidehiro Ishii,et al. Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.
[36] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[37] J. Bennett,et al. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. , 1994, Investigative ophthalmology & visual science.
[38] R. Frank,et al. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. , 1994, Investigative ophthalmology & visual science.
[39] M. Killingsworth,et al. Morphology of early choroidal neovascularisation in age-related macular degeneration: Correlation with activity , 1997, Eye.
[40] Ivana K. Kim,et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.
[41] K. Csaky,et al. Apical Polarity of N-CAM and EMMPRIN in Retinal Pigment Epithelium Resulting from Suppression of Basolateral Signal Recognition , 1998, The Journal of cell biology.
[42] H. Takagi,et al. Expressions of Angiopoietins and Tie2 in Human Choroidal Neovascular Membranes , 2022 .
[43] Y. Fukuda,et al. Adenovirus vector-mediated gene transfer into rat retinal neurons and Müller cells in vitro and in vivo , 1998, Neuroscience Letters.
[44] Matthew A. Thomas,et al. CLINICOPATHOLOGIC STUDIES OF AN EYE AFTER SUBMACULAR MEMBRANECTOMY FOR CHOROIDAL NEOVASCULARIZATION , 1995, Retina.
[45] P. Stewart,et al. Structure of Adenovirus Complexed with Its Internalization Receptor, αvβ5 Integrin , 1999, Journal of Virology.
[46] R. Frank,et al. A model of subretinal neovascularization in the pigmented rat. , 1989, Current eye research.
[47] B. Davidson,et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. , 1994, Investigative ophthalmology & visual science.
[48] Y. Goto,et al. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cells , 1998, Gene Therapy.
[49] Joan W. Miller,et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. , 1996, Investigative ophthalmology & visual science.
[50] S. Coleman,et al. Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. , 1990, Developmental biology.
[51] L. Yannuzzi,et al. CLINICOPATHOLOGIC CORRELATION OF CHOROIDAL NEOVASCULARIZATION DEMONSTRATED BY INDOCYANINE GREEN ANGIOGRAPHY IN A PATIENT WITH RETENTION OF GOOD VISION FOR ALMOST FOUR YEARS , 1994, Retina.
[52] D. Eliott,et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.
[53] H Ueno,et al. Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene. , 1998, Human gene therapy.
[54] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[55] R. D'Amato,et al. Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. , 1993, Microvascular research.
[56] G. Breier,et al. The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.
[57] M. Killingsworth,et al. Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.
[58] B. Davidson,et al. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[59] Y. Ikada,et al. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. , 1999, Investigative ophthalmology & visual science.
[60] R. Crystal,et al. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. , 2000, The Annals of thoracic surgery.
[61] E. Rodriguez-Boulan,et al. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[62] P. Henkind,et al. Ultrastructure of Bruch's membrane after krypton laser photocoagulation. I. Breakdown of Bruch's membrane. , 1986, Archives of ophthalmology.
[63] W. Silverman,et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[65] I. Constable,et al. The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration. , 2000, Investigative ophthalmology & visual science.
[66] Douglas Hanahan,et al. Signaling Vascular Morphogenesis and Maintenance , 1997, Science.